companydata.dkcompanydata.dk

Ranger Biotechnologies A/S: Financial statements 2019

CVR: 32280404

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 591,403 and a net result of DKK -12,653,117 compared with DKK -975,295 the year before. Equity in the 2019 report amounted to DKK 717,366. The solvency ratio was 51.9%. The company had 2 employees in the financial year.

Gross Profit
DKK 591,403
Profit/Loss
DKK -12,653,117
Equity
DKK 717,366
Total Assets
DKK 1,381,798
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-591K-12.7M717K2
2018--832K-975K13.4M1
2017--1.3M-4.9M14.3M1
2016-2.1M1.5M5.9M1
2015--733K-633K4.4M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Ranger Biotechnologies A/S: The 2018 annual report is outJun 14, 2019

Ranger Biotechnologies A/S has published its annual report for 2018. Gross profit came to DKK -831,940, and the net result was DKK -975,295.

About Ranger Biotechnologies A/S

Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.

Source: annual report 2025, Danish Business Authority